| P2093 | author name string | Young Ho Lee | |
| | Ji Young Lee | |
| | Jae-Bum Jun | |
| | Tae-Hwan Kim | |
| | Dae-Hyun Yoo | |
| | Gwan Gyu Song | |
| | Jong Dae Ji | |
| | Sung Jae Choi | |
| | Jin-Hyun Woo | |
| | Jeongwon Sohn | |
| | Yongjin Kim | |
| | Bit-Na-Ra Lee | |
| P2860 | cites work | Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. | Q43564632 |
| | 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level | Q44283041 |
| | Inhibition of p90 ribosomal S6 kinase-mediated CCAAT/enhancer-binding protein beta activation and cyclooxygenase-2 expression by salicylate | Q45287586 |
| | 1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation | Q46665943 |
| | NF-IL6 (C/EBPbeta ) vigorously activates il1b gene expression via a Spi-1 (PU.1) protein-protein tether. | Q51081020 |
| | Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells | Q73709030 |
| | Vitamin D3: a transcriptional modulator of the interferon-gamma gene | Q77530666 |
| | 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation | Q28370605 |
| | Regulation of C/EBPbeta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3 | Q33622844 |
| | Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy | Q33759350 |
| | The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription | Q33853873 |
| | Vitamin D and autoimmunity: new aetiological and therapeutic considerations | Q35954681 |
| | Cells of the synovium in rheumatoid arthritis. Macrophages | Q36465497 |
| | Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor | Q36555534 |
| | Is IL-1 a good therapeutic target in the treatment of arthritis? | Q36596137 |
| | Vitamin D: molecular mechanism of action | Q37033714 |
| | Control of autoimmune diseases by the vitamin D endocrine system | Q37204961 |
| | The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease | Q37381684 |
| | The monocyte/macrophage as a therapeutic target in atherosclerosis | Q37397260 |
| | The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling | Q37521460 |
| | Three Essential Promoter Elements Mediate Tumour Necrosis Factor and Interleukin-1 Activation of the Granulocyte-Colony Stimulating Factor Gene | Q38331651 |
| | Autocrine induction of the human pro-IL-1beta gene promoter by IL-1beta in monocytes | Q40753108 |
| | Involvement of the transcription factor NF-IL6 in phorbol ester induction of P-glycoprotein in U937 cells | Q41130716 |
| | Regulation of IL-1 family cytokines IL-1alpha, IL-1 receptor antagonist, and IL-18 by 1,25-dihydroxyvitamin D3 in primary keratinocytes | Q42491668 |
| | 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis | Q43205828 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2193-2201 | |
| P577 | publication date | 2010-09-17 | |
| P1433 | published in | Molecular Biology Reports | Q15752755 |
| P1476 | title | Upregulation of interleukin-1β production by 1,25-Dihydroxyvitamin D3 in activated human macrophages | |
| P478 | volume | 38 | |